Gene · 2355
Papers2,749
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,749
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Expression of PVRL4, a molecular target for cancer treatment, is transcriptionally regulated by FOS. | Oncol Rep | 2024 | 38063270 | PubTator, text mining | PubMed |
| MethMotif.Org 2024: a database integrating context-specific transcription factor-binding motifs with DNA methylation patterns. | Nucleic Acids Res | 2024 | 37850642 | PubTator, text mining | PubMed |
| HMGA2 promotes nasopharyngeal carcinoma progression and is associated with tumor resistance and poor prognosis. | Front Oncol | 2023 | 38304037 | PubTator, text mining | PubMed |
| HLA-DR expression in melanoma: from misleading therapeutic target to potential immunotherapy biomarker. | Front Immunol | 2023 | 38299143 | PubTator, text mining | PubMed |
| Examining the function of macrophage oxidative stress response and immune system in glioblastoma multiforme through analysis of single-cell transcriptomics. | Front Immunol | 2023 | 38274828 | PubTator, text mining | PubMed |
| The importance of cancer-associated fibroblasts in targeted therapies and drug resistance in breast cancer. | Front Oncol | 2023 | 38273859 | PubTator, text mining | PubMed |
| The role of miRNAs in T helper cell development, activation, fate decisions and tumor immunity. | Front Immunol | 2023 | 38264670 | PubTator, text mining | PubMed |
| Application progress of single-cell sequencing technology in mesenchymal stem cells research. | Front Cell Dev Biol | 2023 | 38264356 | PubTator, text mining | PubMed |
| Noval advance of histone modification in inflammatory skin diseases and related treatment methods. | Front Immunol | 2023 | 38235133 | PubTator, text mining | PubMed |
| The Plastic Interplay between Lung Regeneration Phenomena and Fibrotic Evolution: Current Challenges and Novel Therapeutic Perspectives. | Int J Mol Sci | 2023 | 38203718 | PubTator, text mining | PubMed |
| Identification of genes associated with gall bladder cell carcinogenesis: Implications in targeted therapy of gall bladder cancer. | World J Gastrointest Oncol | 2023 | 38173427 | PubTator, text mining | PubMed |
| Analysis of cancer-associated fibroblasts in cervical cancer by single-cell RNA sequencing. | Aging (Albany NY) | 2023 | 38157264 | PubTator, text mining | PubMed |
| LncRNAs in non-small cell lung cancer: novel diagnostic and prognostic biomarkers. | Front Mol Biosci | 2023 | 38152110 | PubTator, text mining | PubMed |
| The lncRNA FENDRR inhibits colorectal cancer progression via interacting with and triggering GSTP1 ubiquitination by FBX8. | Heliyon | 2023 | 38144314 | PubTator, text mining | PubMed |
| Navigating Tumour Microenvironment and Wnt Signalling Crosstalk: Implications for Advanced Cancer Therapeutics. | Cancers (Basel) | 2023 | 38136392 | PubTator, text mining | PubMed |
| Androgen Receptor/AP-1 Activates UGT2B15 Transcription to Promote Esophageal Squamous Cell Carcinoma Invasion. | Cancers (Basel) | 2023 | 38136265 | PubTator, text mining | PubMed |
| Super-enhancers and the super-enhancer reader BRD4: tumorigenic factors and therapeutic targets. | Cell Death Discov | 2023 | 38135679 | PubTator, text mining | PubMed |
| Exosomal Cargo in Ovarian Cancer Dissemination. | Curr Issues Mol Biol | 2023 | 38132461 | PubTator, text mining | PubMed |
| Epigenomic mapping reveals distinct B cell acute lymphoblastic leukemia chromatin architectures and regulators. | Cell Genom | 2023 | 38116118 | PubTator, text mining | PubMed |
| Unveiling the hidden AP-1: revealing the crucial role of AP-1 in ccRCC at single-cell resolution. | Mol Cancer | 2023 | 38114996 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2355/papers?page=10